Stock Analiz

Benitec Biopharma Inc. (BNTC) stock forecast and price target

Price $9.04 · data as of November 13, 2026

12-month price target

Average target$23.32
Upside / downside+158.0%
Analysts7
ConsensusStrong buy
Low $17.00Average $23.32High $32.00

Gold marker: average target · white marker: today’s price ($9.04)

Analyst ratings

Strong buy 2Buy 6Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends June 30, 2027
$-1.19—$0
Next fiscal year
ends June 30, 2028
$-1.44—$0
Next quarter
ends December 31, 2026
$-0.29—$0
Quarter after
ends March 31, 2027
$-0.31—$0

Consensus of the analysts covering Benitec Biopharma, updated daily. In the last 30 days 0 estimates were raised and 3 lowered.

Frequently asked questions

What is the Benitec Biopharma stock price target?

The average 12-month target from 7 analysts is $23.32, 158.0% above the current price of $9.04 Targets range from $17.00 to $32.00.

Is Benitec Biopharma a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 6 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Benitec Biopharma expected to earn?

Analysts expect EPS of $-1.19 for the fiscal year ending June 30, 2027 and $-1.44 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.